International conference on survivorship care in pediatric oncology

From 27 to 29 June, the 3rd International Symposium on Late Complications after Childhood Cancer (ISLCCC) took place at the University of Lucerne. At this event, experts exchanged ideas and findings from different perspectives in the field of survivorship care in childhood and adolescence cancer.

ISLCCC 2024 Local Organizing Committee with volunteers.

The Symposium brought together physicians, researchers, survivors, parents, and patient advocates from 38 countries covering North America, Europe, Africa, Australia and Asia. Its main aim was to present new research and lessons learned from real-world clinical experience to foster research collaborations and improve care for survivors of cancer in childhood and adolescence worldwide. To this end, three days of presentations, debates, poster sessions, and lectures were held at the University of Lucerne. The organisers consider the event a success, with more than 370 participants both onsite and online.

It featured state-of-the-art and novel findings through 36 oral presentations and 100 posters, carefully selected by a panel of international experts from a wide range of topics related to the survivorship care after childhood and adolescent cancer. Six keynote speakers highlighted different perspectives of the topic of the event: survivorship and its challenges in different countries and regions, physical activity to minimize chronic late effects after childhood and adolescent cancer, approaches to cancer-related fatigue and aspects of photon-/ proton radiotherapy in regards of chronic late effects. A special focus of this year’s symposium was on survivorship care in low- and middle-income countries (LMIC), 13 participants from LMIC were awarded travel grants to present their work at the meeting.

The ISLCCC symposium takes place in alternation between Europe and North America each year and is led by an international steering committee. For the organization of this year’s edition in Switzerland, a team around Professor Dr. Gisela Michel and Professor Dr. med. Katrin Scheinemann was responsible. This meeting was made possible through the support of Zoé4Life and Kinderkrebshilfe Schweiz, Stiftung für krebskranke Kinder Regio Basiliensis, Swiss National Science Foundation, and Lucerne Tourism.

Further information:www.islccc.org